Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Zika Vaccine Candidate

NIH RePORTER · NIH · N01 · $113,642 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID: 10656146
Project number: 272201300021I-P00003-27200014-1
Recipient: SAINT LOUIS UNIVERSITY
Principal Investigator: SARAH GEORGE
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $113,642
Award type: —
Project period: 2013-09-16 → 2023-05-31